Chronic lung disease in children and adolescents with HIV: a case–control study

Objective To describe the features of HIV‐associated chronic lung disease (CLD) in older children and adolescents living with HIV and to examine the clinical factors associated with CLD. This is a post hoc analysis of baseline data from the BREATHE clinical trial (ClinicalTrials.gov, NCT02426112). M...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Tropical medicine & international health 2020-05, Vol.25 (5), p.590-599
Hauptverfasser:	McHugh, Grace, Rehman, Andrea M., Simms, Victoria, Gonzalez‐Martinez, Carmen, Bandason, Tsitsi, Dauya, Ethel, Moyo, Brewster, Mujuru, Hilda, Rylance, Jamie, Sovershaeva, Evgeniya, Weiss, Helen A., Kranzer, Katharina, Odland, Jon, Ferrand, Rashida A., Corbett, Elizabeth L, Flaegstad, Trond, Gutteberg, Tore J, Cavanagh, Jorunn Pauline, Majonga, Edith, Dube, Felix, Mhbele, Slee, Yindom, Louis‐Marie, Rowland‐Jones, Sarah, Nicol, Mark
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adolescents Africa Afrique Age Antiretroviral agents Antiretroviral therapy Bronchodilation Bronchodilators Case-Control Studies Child Child Health Services Children chronic lung disease Cough Female HIV HIV Infections HIV-1 Human immunodeficiency virus Humans Lung diseases Lung Diseases - complications Lung Diseases - epidemiology maladie pulmonaire chronique Malawi - epidemiology Male Regression analysis Respiration Respiratory rate Salbutamol Sexually transmitted diseases Signs and symptoms STD Surveys and Questionnaires Survivors Teenagers VIH Young Adult Youth Zimbabwe - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Objective To describe the features of HIV‐associated chronic lung disease (CLD) in older children and adolescents living with HIV and to examine the clinical factors associated with CLD. This is a post hoc analysis of baseline data from the BREATHE clinical trial (ClinicalTrials.gov, NCT02426112). Methods Children and adolescents aged 6–19 years were screened for CLD (defined as a FEV1 z‐score
ISSN:	1360-2276 1365-3156
DOI:	10.1111/tmi.13375